The Expression of Epidermal Growth Factor Receptor, HER-2/ Neu, p53, and Ki-67 Antigen in Uterine Malignant Mixed Mesodermal Tumors and Adenosarcoma

By Swisher E.M.   Gown A.M.   Skelly M.   Ek M.   Tamimi H.K.   Cain J.M.   Greer B.E.   Muntz H.G.   Goff B.A.  

Gynecologic Oncology, Vol. 60, Iss. 1, 1996-01 ,pp. : 81-88

Academic Press

Access to resources Recommend Favorite

Overexpression of p53 Is Not a Feature of Ovarian Granulosa Cell Tumors

By Liu F.S.   Ho E.S.C.   Lai C.R.   Chen J.T.   Shih R.T.P.   Yang C.H.   Tsao C.M.  

Gynecologic Oncology, Vol. 61, Iss. 1, 1996-04 ,pp. : 50-53

Academic Press

Access to resources Recommend Favorite

Different detection rates of HER-2/NEU overexpression in ovarian carcinoma using two different commercially available detection kits

By Romero H.   Schneider J.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 1020-1021

Elsevier

Access to resources Recommend Favorite

S-Phase Fraction, p53, and HER-2/neu Status as Predictors of Nodal Metastasis in Early Vulvar Cancer

By Gordinier M.E.   Steinhoff M.M.   Hogan J.W.   Peipert J.F.   Gajewski W.H.   Falkenberry S.S.   Granai C.O.  

Gynecologic Oncology, Vol. 67, Iss. 2, 1997-11 ,pp. : 200-202

Elsevier

Access to resources Recommend Favorite

Alternations of ER, PR, HER-2/neu, and P53 protein expression in ductal breast carcinomas and clinical implications

By Liu Caigang   Zhang Hao   Shuang Chen   Lu Yang   Jin Feng   Xu Huimian   Lu Ping  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 747-752

Humana Press, Inc

Access to resources Recommend Favorite